These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16121312)

  • 1. Genetics of pulmonary arterial hypertension: current and future implications.
    Elliott CG
    Semin Respir Crit Care Med; 2005 Aug; 26(4):365-71. PubMed ID: 16121312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis of pulmonary arterial hypertension: current understanding and future directions.
    Newman JH; Trembath RC; Morse JA; Grunig E; Loyd JE; Adnot S; Coccolo F; Ventura C; Phillips JA; Knowles JA; Janssen B; Eickelberg O; Eddahibi S; Herve P; Nichols WC; Elliott G
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):33S-39S. PubMed ID: 15194176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.
    Smoot LB; Obler D; McElhinney DB; Boardman K; Wu BL; Lip V; Mullen MP
    Arch Dis Child; 2009 Jul; 94(7):506-11. PubMed ID: 19357124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
    Fujiwara M; Yagi H; Matsuoka R; Saji T
    Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of pulmonary hypertension: from bench to bedside.
    Humbert M; Trembath RC
    Eur Respir J; 2002 Sep; 20(3):741-9. PubMed ID: 12358355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic clues to the cause of primary pulmonary hypertension.
    Loscalzo J
    N Engl J Med; 2001 Aug; 345(5):367-71. PubMed ID: 11484696
    [No Abstract]   [Full Text] [Related]  

  • 9. Idiopathic pulmonary hypertension: what did we learn from genes?
    Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes and pulmonary arterial hypertension.
    Sztrymf B; Yaïci A; Girerd B; Humbert M
    Respiration; 2007; 74(2):123-32. PubMed ID: 17318011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
    Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
    Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations of genes coding for TGF-beta receptors (BMPR2 and ALK-1) in primary pulmonary arterial hypertension].
    Humbert M
    J Soc Biol; 2002; 196(1):53-8. PubMed ID: 12134634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular genetic features of hereditary pulmonary arterial hypertension.
    Brenner L; Chung WK
    Compr Physiol; 2011 Oct; 1(4):1721-8. PubMed ID: 23733703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension.
    Eyries M; Coulet F; Girerd B; Montani D; Humbert M; Lacombe P; Chinet T; Gouya L; Roume J; Axford MM; Pearson CE; Soubrier F
    Clin Genet; 2012 Aug; 82(2):173-9. PubMed ID: 21651515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.
    Harrison RE; Berger R; Haworth SG; Tulloh R; Mache CJ; Morrell NW; Aldred MA; Trembath RC
    Circulation; 2005 Feb; 111(4):435-41. PubMed ID: 15687131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
    Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
    J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
    Humbert M; Labrune P; Simonneau G
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S93-6. PubMed ID: 12373580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.